GlassScriptPhysician profile
Basil M Paulus
NPI 1073731592
$66,786.59
in general payments reported to CMS, 2019-2025
48 companies · $39K in 2025
The $39K reported for 2025 was more than what 96% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,397 · 2020: $5,247 · 2021: $2,855 · 2022: $3,161 · 2023: $5,055 · 2024: $8,489 · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Food and Beverage: $15K · Travel and Lodging: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,645.00 |
| Food and Beverage | $15,202.37 |
| Travel and Lodging | $12,041.12 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $237.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $39,011.92 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $10,053.75 | 2019-2025 | Mitraclip, Navitor, Cardiomems |
| Medtronic, INC. | $5,401.96 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Medtronic Vascular, INC. | $4,196.56 | 2019-2020 | |
| Shockwave Medical, INC | $1,062.53 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $874.45 | 2019-2025 | Impella |
| Boston Scientific Corporation | $847.42 | 2019-2025 | Avvigo Guidance System, Sentinel, Eluvia |
| Amgen INC. | $590.51 | 2019-2025 | Repatha, Repatha |
| Chiesi USA, INC. | $433.25 | 2019-2024 | Kengreal, Cleviprex |
| Astrazeneca Pharmaceuticals LP | $431.27 | 2019-2025 | Farxiga, Wainua |
| Zoll Circulation INC | $406.96 | 2024-2025 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Livanova USA, INC. | $372.97 | 2019-2023 | Lifesparc |
| Boehringer Ingelheim Pharmaceuticals, INC. | $363.11 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $291.24 | 2019-2024 | Xarelto |
| Cordis US Corp. | $229.72 | 2024 | Mynx Venous Vcd, Selution Slrpta |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $194.97 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| W. L. Gore & Associates, INC. | $180.94 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| E.R. Squibb & Sons, L.L.C. | $180.40 | 2023-2025 | Camzyos, Eliquis |
| Pfizer INC. | $179.66 | 2019-2024 | |
| Angiodynamics, INC. | $158.64 | 2024-2025 | Alphavac, Auryon Laser System 100-120 Vac |
| Contego Medical, INC | $132.45 | 2024 | |
| Avinger INC. | $105.27 | 2019-2022 | |
| Cardiva Medical, INC. | $102.09 | 2023-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade 5f Vcs |
| Novartis Pharmaceuticals Corporation | $94.93 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $80.26 | 2024-2025 | Lifevest |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $79.19 | 2019 | |
| Inari Medical, INC. | $72.79 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Lilly USA, LLC | $71.25 | 2023-2025 | Zepbound, Mounjaro |
| Regeneron Healthcare Solutions, INC. | $68.59 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.78 | 2025 | |
| Cvrx, INC. | $55.10 | 2023-2024 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $48.47 | 2019 | |
| Altathera Pharmaceuticals LLC | $38.81 | 2023 | Sotalol Hydrochloride |
| Xeris Pharmaceuticals, INC. | $38.49 | 2024 | Keveyis |
| Alnylam Pharmaceuticals INC. | $37.92 | 2025 | Amvuttra |
| Terumo Medical Corporation | $26.27 | 2024 | Glidewire |
| Philips North America LLC | $24.06 | 2024 | (Br0) Coronary Atherectomy |
| Cardiovascular Systems INC. | $23.03 | 2019 | |
| Penumbra, INC. | $22.27 | 2023 | Penumbra System |
| Bridgebio Pharma, INC. | $22.06 | 2025 | Attruby |
| Bard Peripheral Vascular, INC. | $19.79 | 2019 | |
| Opsens INC. | $19.75 | 2023 | Optowire |
| Amarin Pharma, INC. | $18.80 | 2019 | |
| Nuwellis, INC. | $18.62 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $17.86 | 2023 | Opsumit, Uptravi |
| Vivaquant INC, Dba Rhythm Express | $16.79 | 2025 | Rhythm Express |
| Vasorum USA INC. | $6.67 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basil Paulus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.